Verrica Pharmaceuticals I... (VRCA)

0.66

0.01 (1.68%)

At close: Mar 03, 2025, 3:59 PM

0.64

-2.54%

After-hours: Mar 03, 2025, 04:00 PM EST

Verrica Pharmaceuticals Cash Flow Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16
Net Income	-67M	-24.49M	-35.08M	-42.69M	-28.21M	-20.65M	-4.46M	-1.91M
Depreciation & Amortization	836K	718K	472K	229K	257K	20K	n/a	n/a
Stock-Based Compensation	14.38M	4.99M	6.05M	9.82M	3.33M	2.25M	82K	9K
Other Working Capital	11.59M	-1.46M	-1.03M	2.47M	-1.95M	145K	-270K	222K
Other Non-Cash Items	3.35M	1.93M	1.44M	940K	-1.06M	-435K	18K	-62K
Deferred Income Tax	n/a	n/a	66K	-138K	n/a	n/a	n/a	n/a
Change in Working Capital	9.86M	-1.8M	-535K	1.64M	-1.73M	938K	-206K	293K
Operating Cash Flow	-38.58M	-18.65M	-27.58M	-30.21M	-27.41M	-17.87M	-4.58M	-1.61M
Capital Expenditures	-362K	-302K	-883K	-1.47M	-682K	-774K	n/a	n/a
Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	-4.49M	-68.91M	-71.74M	-89.85M	-79.12M	n/a	n/a
Sales Maturities Of Investments	n/a	59.01M	69M	69.85M	117.72M	n/a	n/a	n/a
Other Investing Acitivies	n/a	-180K	-201K	-221K	-1.22M	-499K	n/a	n/a
Investing Cash Flow	-362K	54.04M	-998K	-3.58M	25.95M	-79.89M	n/a	n/a
Debt Repayment	44.08M	-43.75M	4.97M	34.46M	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-169K	-17K	558K	772K	423K	21M	12.72M	483K
Financial Cash Flow	74.21M	-16.87M	33.65M	35.23M	423K	99.38M	12.72M	483K
Net Cash Flow	35.27M	18.52M	5.07M	1.45M	-1.03M	1.61M	8.14M	-1.13M
Free Cash Flow	-38.94M	-18.95M	-28.46M	-31.68M	-28.09M	-18.65M	-4.58M	-1.61M